Skip to main content

Preferred Sample Type

Argatroban

Argatroban

Specimen Volume

3.5 mL (Vacuette tubes) or 2.7mL (BD Vacutainer tubes)

Specimen Transport

Standard transport to laboratory

Sample Preparation

Samples must be filled to the black fill line (Vacuette tubes) or the frosted line (BD Vacutainer tubes) indicated on the sample tube. Any sample filled above or below this level will be rejected and a repeat sample will be required

Turnaround Time

7 days (Unless urgent by prior arrangement with laboratory)

Sample Processing In Laboratory

Sample should be centrifuged

Sample Stability

12 hours from venepuncture (ideally received no later than 4 hours after collection)

General Information

Test Availability:

Queen Elizabeth only

Samples received at other sites will be sent on to the Queen Elizabeth Laboratory.

External Requests:

Note: For external requests please click Here for Coagulation Disorders request form. Please complete all information fully.

Sample packing and transportation:

Frozen plasma should be sent on dry ice using an insulated container to ensure that it remains frozen during transport. Please refer to the preanalytical variables section of the BSH guidelines on the laboratory aspects of assays used in haemostasis and thrombosis1.

As an alternative the bio-freeze container system can be used to ensure samples remain frozen in transit. These have been locally validated to maintain samples at -20oC for up to 12 hours  providing they have been preconditioned in a -80oC freezer for 24 hours prior to use.

IMPORTANT: If sending samples to more than one department separate transport containers must be used. DO NOT package samples for different departments in the same container. This may lead to a loss of sample integrity when samples have to be unpacked and distributed to multiple departments.  

Address:

Transport containers should be specifically labelled to ensure they are delivered to the correct location:

Special Coagulation, Haematology Laboratory, Clinical Laboratory Services, Level -1, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW.  

Disclaimer:

Please note failure to use an appropriate transit container may affect sample integrity, thus the accuracy of results cannot be guaranteed.  Furthermore, samples packaged incorrectly that arrive in a thawed state cannot be tested.

Please contact the laboratory on 0121 371 5988 (Queen Elizabeth Hospital) if you require any further information.

1) Baker, P., Platton, S., Gibson, C., Gray, E., Jennings, I., Murphy, P., Laffan, M. and British Society for Haematology, Haemostasis and Thrombosis Task Force (2020), Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Br. J. Haematol., 191: 347-362.

https://doi.org/10.1111/bjh.16776

Samples that meet the following criteria will not be processed:

  • Haemolysed, clotted, underfilled or overfilled samples.
  • Samples >12 hours old from the time of collection.
  • Samples received from other hospital laboratories that have been frozen and thawed.
  • Samples which fail the minimum data set.

Assay Limitations:

No interferences up to:

Haemoglobin: 1000 mg/dl

Triglycerides: 875 mg/dl

Bilirubin (Free): 60 mg/dl         

Bilirubin (Conjugated): 60 mg/dl        

Apixaban: 100 ng/dl

In addition, the reagent does not contain heparin inhibitors, therefore interference by edoxaban, rivaroxaban and heparins on assay results could be shown.

Notes

Argatroban is a direct thrombin inhibitor (DTI) used as an anticoagulant in patients with confirmed or suspected Heparin Induced Thrombocytopenia (HIT). Click Here for more details.

Reference Range

The therapeutic range for the argatroban assay is 0.4-1.2µg/ml

Specifications

  • EQA Status: ECAT
  • EQAS Scheme: Yes